Disclosed are a dental material with transmittance and color gradients and a method of preparing the dental material. The method includes (1) preparing at least three types of composite resin material precursor powders; (2) sequentially adding the precursor powders into a mold and performing dry pressing to obtain a preform body; alternatively, (2′) dry pressing the first type of precursor powder into a first green body, wrapping the first green body with the second type of precursor powder and then performing dry pressing to obtain a second green body, and repeating the wrapping and dry pressing operations until all types of precursor powder are dry pressed to obtain a preform body; and (3) performing hot-pressing consolidation on the preform body to obtain the desired dental material.

Radically polymerizable dental material, which contains at least one ABA or AB block copolymer, preferably at least one monofunctional, radically polymerizable monomer (a) and preferably at least one radically polymerizable urethane di(meth)acrylate telechel (b).

Radically polymerizable dental material, which contains at least one ABA or AB block copolymer, preferably at least one monofunctional, radically polymerizable monomer (a) and preferably at least one radically polymerizable urethane di(meth)acrylate telechel (b).

Disclosed are a dental gradient color-resin ceramic restoration material and a preparation method thereof. The method includes: preparing at least two paste materials with different colors, respectively dispersing the paste materials with different colors at a certain speed and under a vacuum of -0.01-0.1 MPa to obtain at least two granular materials with different colors having an average size of 0.1 mm to 5 mm; spreading the at least two granular materials with different colors to be flat in a mould in sequence to obtain at least two layers, and then tightly combining the at least two layers at a pressure of 0.5-5 MPa to obtain a semi-finished product of a gradient color-resin ceramic restoration material; polymerizing and curing the semi-finished product at 60-200° C. and 2-50 MPa to obtain a multilayer gradient color-resin ceramic restoration material.

An implant abutment according to the present invention is a dental implant abutment with an enhanced shock distribution function, the dental implant abutment comprising: an upper coupling portion that is an upper portion coupled to an artificial tooth; a lower coupling portion that is a lower portion coupled to a fixture, and an exposed portion that is exposed to the outside between the upper coupling portion and the lower coupling portion and has a plurality of flow grooves. By forming a plurality of grooves in the exposed portion of the implant abutment, the exposed portion of the implant abutment performs a shock distribution function as if it shakes elastically and distributes an occlusal force of teeth exerted to the implant, thereby providing a buffering function of relieving an impact on an area where the implant is inserted.

An implant abutment according to the present invention is a dental implant abutment with an enhanced shock distribution function, the dental implant abutment comprising: an upper coupling portion that is an upper portion coupled to an artificial tooth; a lower coupling portion that is a lower portion coupled to a fixture, and an exposed portion that is exposed to the outside between the upper coupling portion and the lower coupling portion and has a plurality of flow grooves. By forming a plurality of grooves in the exposed portion of the implant abutment, the exposed portion of the implant abutment performs a shock distribution function as if it shakes elastically and distributes an occlusal force of teeth exerted to the implant, thereby providing a buffering function of relieving an impact on an area where the implant is inserted.

A pharmaceutical formulation for topical dental administration or medical (e.g., implant) treatment, including effective amounts of: at least one antimicrobial compound; at least one peroxide source compound; and at least one gel agent. Also disclosed are methods of oral anatomy treatment. The pharmaceutical formulation and treatment methods provide the patient with oral anatomy benefits including, for example, decreased or arrested gum recession; decreased or arrested bone recession; decreased or arrested bone mass loss; decreased or eliminated pain; decreased or eliminated bleeding; decreased or eliminated swelling; enhanced regeneration of bone; enhanced soft tissue repair; or a combination thereof.

A pharmaceutical formulation for topical dental administration or medical (e.g., implant) treatment, including effective amounts of: at least one antimicrobial compound; at least one peroxide source compound; and at least one gel agent. Also disclosed are methods of oral anatomy treatment. The pharmaceutical formulation and treatment methods provide the patient with oral anatomy benefits including, for example, decreased or arrested gum recession; decreased or arrested bone recession; decreased or arrested bone mass loss; decreased or eliminated pain; decreased or eliminated bleeding; decreased or eliminated swelling; enhanced regeneration of bone; enhanced soft tissue repair; or a combination thereof.

A photocurable composition includes a photopolymerizable component and a photopolymerization initiator. When a test piece with a length of 39 mm, a width of 8 mm, and a thickness of 4 mm, is produced by photofabrication under conditions in which the photocurable composition is irradiated with visible light having a wavelength of 405 nm at an irradiation dose of 12 mJ/cm.sup.2 to form a cured layer with a thickness of 100 .Math.m, the cured layer is stacked in a thickness direction thereof to form a rectangular fabrication product with a length of 39 mm, a width of 8 mm, and a thickness of 4 mm, and the fabrication product is irradiated with ultraviolet rays having a wavelength of 365 nm at an irradiation dose of 10 J/cm.sup.2 to produce the test piece, a total fracture work of the test piece measured in compliance with ISO20795-1:2008 is 1100 J/m.sup.2 or more.

The present invention relates in a first aspect to an adhesion material for use in an individual containing encapsulated phase-change material. In particular, the adhesion material is for cosmetical or medicinal use in the body of an individual. The adhesion material contains encapsulated phase-change material having preferably a phase transition temperature above 40° C., like above 55° C. The adhesion material is particularly useful for adhering elements, like dental restorations, e.g. crowns or bridge, or brackets on elements in the body of an individual, like teeth or implants. That is, the adhesion material is particularly useful for adhering material in dental applications. In another aspect, a method is provided allowing removing a bracket, a crown or bridge, from implants, abutments or teeth. Furthermore, dental implant restoration systems and kits for permanent fixation of implants allowing improved removal thereof are provided.